Condition
Peripheral Neuropathy clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Peripheral Neuropathy clinical trials that are recruiting, at sites in 7 countries (most in United States (12), Egypt (2), Greece (1)). By phase: Phase 1 (1), Phase 4 (1), Phase 2 (1). There are also 74 NIH-funded research projects on Peripheral Neuropathy, with $38.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 74NIH research projects
- 7Countries
Newest Peripheral Neuropathy clinical trials
All recruiting trials (18)
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
-
Acupuncture and Exercise for EV-Pembro–Induced Peripheral Neuropathy
This study tests whether adding acupuncture to a gentle virtual exercise program helps reduce chemotherapy-induced nerve problems in bladder cancer patients taking EV and pembrolizumab.
-
Tai Chi, alpha-lipoic acid, and acupuncture to reduce chemotherapy-related peripheral neuropathy in people treated for gastrointestinal cancers.
This 16-week pilot will try virtual Tai Chi/Qi Gong or alpha-lipoic acid, adding acupuncture for those who don't improve, to see if these approaches reduce chemo-related nerve numbness and tingling in people treated for GI cancers.
-
Adaptive transcutaneous magnetic stimulation for posttraumatic peripheral neuropathic pain
This project will try adaptive transcutaneous magnetic stimulation (AtMS) to see if it reduces post-traumatic peripheral neuropathic pain in veterans and active-duty military.
-
Leia sensory prosthesis for balance and gait in people with peripheral neuropathy
A wearable, non-invasive device is tested to see if it helps adults with peripheral neuropathy walk more stably and balance better over a set period.
-
Desloratadine to see if it can prevent nerve damage from taxane chemotherapy in breast cancer
A randomized, placebo-controlled test to see if desloratadine can help prevent taxane-induced peripheral neuropathy in adults with breast cancer.
-
Nerve excitability testing for cisplatin-related peripheral neuropathy
This study will see if specialized nerve excitability tests (TTNCS) can detect early nerve changes in adults starting cisplatin or who recently finished cisplatin and have peripheral neuropathy.
-
Fenofibrate to prevent nerve damage from VRd (bortezomib/lenalidomide/dexamethasone) in multiple myeloma
This tests whether adding fenofibrate to standard VRd chemotherapy can reduce bortezomib-related peripheral neuropathy in adults newly diagnosed with multiple myeloma.
-
Real-time pressure controller to prevent peripheral neuropathy from albumin-bound paclitaxel
This trial will test whether a real-time pressure controller can reduce numbness, tingling, and nerve pain in adults getting albumin-bound paclitaxel for breast cancer.
-
Using ultrasound to improve diagnosis of nerve disorders like GBS and CIDP
This study is testing if using ultrasound can help doctors better diagnose nerve disorders like Guillain-Barré Syndrome and CIDP by comparing ultrasound results with other nerve tests.
-
Assessing gait and balance in rare neurological diseases
This study looks at how walking and balance are affected in people with rare neurological diseases to better understand their challenges and risks of falling.
-
Assessing force measurement in carbon fiber orthoses
This study is testing how well special sensors can measure force in carbon fiber ankle-foot braces to see how they work for healthy people and those with nerve issues.
-
Wearable Insoles to Help Prevent Diabetic Foot Ulcers
This study tests Orpyx sensory insoles added to standard care to see if they reduce diabetic foot ulcers in high-risk adults with neuropathy.
-
Preventing nerve damage from chemotherapy in colorectal cancer patients
This study is testing if high doses of omega-3 fatty acids can help prevent nerve damage in colorectal cancer patients who are getting chemotherapy.
-
Using ultrasound to study nerves and muscles
This study is testing how ultrasound can help us learn more about the health of nerves and muscles in both healthy adults and those with neuromuscular disorders.
-
Using stem cell exosomes to treat Trigeminal Neuralgia
This study is testing if a treatment using stem cell exosomes can help people with Trigeminal Neuralgia feel better and reduce their pain.
-
Intermittent Dorsal Root Ganglion Stimulation for Chronic Pain Relief
This study is testing if a new way of using nerve stimulation can help people with chronic pain feel better compared to the usual constant treatment.
-
Investigating the role of amylin in diabetic nerve damage
This study is trying to see if the levels of a hormone called amylin are linked to nerve damage in people with Type-2 diabetes.
NIH-funded research (newest 40 of 74)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Novel pain biomarker for neuropathy that could guide therapy
A study to develop and test a biomarker that reflects how well peripherally acting pain medicines work for people with painful peripheral neuropathy.
-
Auricular vagus nerve stimulation to help HIV-related nerve pain in older adults
A new, non-invasive brain-nerve stimulation approach is being tested to help older adults living with HIV who have nerve pain.
-
Longitudinal study of how body-sense relates to chemotherapy nerve damage
This study follows people with breast or gastrointestinal cancer and healthy controls to see if brain processing of body sensations contributes to chemotherapy-induced nerve damage.
-
Understanding how early nerve excitement during chemotherapy leads to painful nerve damage
A cancer treatment study looks at why the nerve pain some patients get after paclitaxel may develop, by studying how nerves react during the infusion.
-
A new screen for chemotherapy-related nerve problems in young children
A clinician-scientist at Yale is developing a child-friendly survey to quickly screen for nerve-related side effects from cancer treatment in kids from birth to age 5.
-
Understanding nerve damage in Spinocerebellar Ataxia Type 3
A study in people with SCA3 explores how the disease affects the peripheral nerves and what that means for symptoms like numbness or weakness.
-
How the immune system’s CD4+ T cells in women might prevent chemotherapy-related nerve pain
A study in mice explores whether female immune cells in nerve tissue can lessen pain from chemotherapy, with potential implications for preventing CIPN in women.
-
Axonal transport and chemotherapy-related nerve pain
This grant studies why certain cancer patients develop painful nerve damage from chemotherapy and explores ways to prevent or treat it.
-
Daily home-based TENS for painful CIPN: phase III confirmatory trial
A big, multi-site study will test whether a home-based, wireless TENS device can relieve painful chemotherapy-induced peripheral neuropathy in cancer patients.
-
Remote monitoring and nurse follow-up to manage chemotherapy-induced peripheral neuropathy
A program uses symptom reporting tools with nurse follow-up to reduce and better manage chemotherapy-induced neuropathy for cancer survivors, during and after treatment.
-
Non-opioid pain relief for chemotherapy-related nerve pain using CART II
A study tests a brain-acting peptide called CART II to help reduce pain from chemotherapy-induced nerve damage without opioids.
-
New oral TAK1 inhibitor to help with chemotherapy-related nerve pain
A new oral drug candidate aims to prevent or lessen nerve damage and pain caused by certain chemotherapy treatments in cancer patients.
-
Remotely Delivered Tai Chi to Help Older GI Cancer Patients with Chemotherapy-Related Nerve Pain
A study will test a home-based Tai Chi program to ease nerve pain and improve function for GI cancer patients aged 65 and older who are experiencing chemotherapy-related neuropathy.
-
Non-invasive microscopic biomarkers to track chemotherapy-caused nerve pain
A study at the University of Arizona will test a non-invasive imaging method to visualize tiny nerve endings in the skin to help understand and monitor chemotherapy-induced peripheral neuropathy in cancer patients.
-
Gut bacterial vesicles and diabetic nerve damage
This work looks at whether tiny particles released by gut bacteria can protect nerves and ease numbness and pain in people with diabetic peripheral neuropathy.
-
Predicting nerve damage risk from taxane chemotherapy
This project builds a tool to predict which patients getting taxane chemotherapy are likely to develop peripheral neuropathy.
-
New ways to prevent and reverse chemotherapy-related nerve damage
Researchers are trying approaches that block a nerve‑destroying protein to prevent or reverse painful nerve damage in people treated with chemotherapy.
-
Restoring sensation in amputated limbs for veterans with diabetic neuropathy
This study is looking to help veterans who have lost lower limbs due to diabetic peripheral neuropathy by using special electrodes to create sensations that feel like they're coming from their missing foot, which could improve their daily activities and overall limb health.
-
Skin nerve–immune links in chemotherapy-related hand and foot nerve pain
This project looks at how interactions between skin nerves and the immune system may cause long-lasting hand and foot nerve pain after the chemotherapy drug oxaliplatin.
-
Blocking NLRP3 to treat paclitaxel-related nerve pain
This project looks at whether blocking the NLRP3 inflammasome can help adults who get nerve pain from paclitaxel chemotherapy.
-
Wearable vibration to improve movement and reduce pain in diabetic nerve damage
A wearable vibration device is tested for four weeks to help adults with diabetic peripheral neuropathy walk better and experience less pain.
-
SP16 to prevent chemotherapy-related nerve damage
This project tries to prevent or reduce nerve pain and lasting nerve damage from taxane chemotherapy using a new drug called SP16 that activates the LRP1 receptor.
-
How the brain's sensing of the body affects chemo-related nerve symptoms
Researchers will follow people with breast or gastrointestinal cancer getting taxane or platinum chemotherapy and healthy volunteers to learn whether changes in the brain's body-sensing relate to nerve symptoms after chemotherapy.
-
How early nerve over-activation during paclitaxel treatment may cause chemotherapy-related peripheral neuropathy
This project looks at whether paclitaxel causes early over-activation of sensory nerves that leads to energy failure in nerve fibers and later painful peripheral neuropathy in people treated with paclitaxel.
-
Improving walking and reducing foot pressure for people with diabetic nerve damage
This project tries real-time biofeedback to change how adults with diabetic peripheral neuropathy walk so they have lower harmful foot pressure and better walking speed.
-
Finding new ways to treat painful nerve damage caused by chemotherapy
This study is looking at the painful nerve damage that some cancer survivors experience from chemotherapy, and it's trying to find new ways to help reduce that pain so they can feel better.
-
Low-Intensity Vibration to Reduce CIPN Symptoms After Chemotherapy
A home-based, drug-free therapy using a vibrating platform aims to lessen nerve pain and improve movement for adults who have finished chemotherapy.
-
Investigating how microRNA affects nerve protection to reduce pain from chemotherapy and Alzheimer's.
This study is looking at how a tiny molecule and a specific protein might help protect nerves from damage caused by chemotherapy and Alzheimer's, using fruit fly larvae to learn more about nerve pain and find new ways to help people feel better.
-
How immune cells in women might protect against nerve pain from chemotherapy
This project explores how certain immune cells in female bodies may naturally reduce nerve pain caused by chemotherapy, aiming to find new ways to prevent this side effect.
-
New treatments for nerve pain caused by chemotherapy
This study is looking for new medications to help manage nerve pain that some people experience after chemotherapy, focusing on a protein called CRMP2, with the hope of finding safer treatments that don't involve opioids.
-
Managing nerve pain caused by chemotherapy through remote monitoring
This study is testing a new way to help people who have painful nerve issues after chemotherapy by using a symptom reporting tool and follow-up calls from nurses to make sure they get the support they need.
-
New methods to detect nerve damage from chemotherapy
This study is looking at a new way to see and measure nerve damage in the skin caused by chemotherapy, which can help doctors better understand and manage the symptoms for cancer patients dealing with nerve pain.
-
Mobile app teaching caregivers massage techniques for chemotherapy-related nerve pain
This study is creating a friendly mobile app called 'Peripheral Neuropathy Relief' to help caregivers learn easy massage techniques that can ease the discomfort of cancer survivors dealing with nerve pain from chemotherapy.
-
Understanding and treating nerve damage from chemotherapy
This project looks at how chemotherapy causes nerve damage in cancer patients.
-
Antibody-based treatment for nerve pain from oxaliplatin chemotherapy
This project tests a small engineered antibody-like drug to relieve long-lasting nerve pain in people treated with oxaliplatin chemotherapy.
-
Understanding how aging cells contribute to nerve pain after chemotherapy
This study is looking at how certain aging cells in the body might cause the painful nerve problems that some cancer survivors experience after chemotherapy, with the hope of finding new ways to help manage or prevent these symptoms.
-
Investigating how microRNA affects nerve protection to reduce pain from chemotherapy
This study is looking at how tiny molecules called microRNAs can help a protein that protects nerves from damage caused by chemotherapy, with the hope of finding new ways to help people who experience nerve pain after cancer treatment.
-
Spinal cord stimulation for nerve pain from chemotherapy and better cancer treatment
This project explores how spinal cord stimulation might reduce nerve pain caused by chemotherapy and improve the effectiveness of cancer drugs.
-
Investigating a new treatment for pain caused by chemotherapy
This study is looking at a new treatment called CART II to help relieve the painful nerve issues that some cancer patients experience after chemotherapy, and it aims to find a safer way to manage that pain for everyone.
Related topics
Quick answers
How many Peripheral Neuropathy clinical trials are recruiting right now?
18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (12 trials), Egypt (2 trials), Greece (1 trial), Switzerland (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.